Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical hematopoietic stem cell transplantation using Campath-1H
IRCT138706061030N2Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of alemtuzumab in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Tehran University of Medical Sciences. Started Sep 2006; status: completed.
02
Drugs
alemtuzumab
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT138706061030N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138706061030N2.